Skip to content

Verification of intestinal environment improvement and effect on cold symptoms by amazake long-term intake

Verification of intestinal environment improvement and effect on cold symptoms by amazake long-term intake - Verification of intestinal environment improvement and effect on cold symptoms by amazake long-term intake

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044117
Enrollment
100
Registered
2021-06-30
Start date
2020-11-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Amazake made by rice koji and sake lees is taken once a day Placebo drink of control 3 is taken once a day

Sponsors

MORINAGA & CO., LTD.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Regular visitors to Matsuike Clinic (those with mild constipation who are prescribed magnesium oxide) or healthy adults recruited by expressing their intention to participate directly with the investigator. 2) Those who are 20 to 60 years old at the time of obtaining consent to participate in the exam 3) Those who have received sufficient explanation about the purpose and contents of this test, have the ability to consent, voluntarily volunteer to participate after understanding it well, and can consent to participate in this test in writing. 4) Those who can come to the hospital on the designated date and receive interviews 5) Those who the investigator deems appropriate to participate in this study

Exclusion criteria

Exclusion criteria: 1) Persons with symptoms other than mild constipation 2) Those who cannot be judged by the investigator as having no influence on the participation in the examination regarding the medical history 3) Persons who may cause allergic symptoms to the ingredients contained in the test food 4) Those who habitually consume amazake (regardless of manufacturer) 5) Those planning to become pregnant, lactating or possibly pregnant and pregnant during the study period 6) Persons with alcoholism or other mental disorders 7) Persons who may change their lifestyle during the examination period (night shift, long-term travel, etc.) 8) Those who plan to take new health foods and supplement foods during the test period 9) Those who have been treated with hospitalization within the past 6 months 10) Those who are currently participating in other human clinical trials, those who have not passed 3 months since participating in other human clinical trials 11) Others who are judged by the investigator to be inappropriate for this study

Design outcomes

Primary

MeasureTime frame
alteration of intensional bacterial flora and effect on cold symptoms

Secondary

MeasureTime frame
Bowel movement

Countries

Japan

Contacts

Public ContactSadao Mori

MORINAGA & CO., LTD. R & D Center

s-mori-ab@morinaga.co.jp045-571-6140

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026